SANLORENZOSPA/AMEGLIA financials
SANLORENZOSPA/AMEGLIA
Country: IT Reporting currency: EUR Latest annual report: 2022-12-31
LEI:
8156006C71E895860132 ISIN: IT0003549422 Financial statements
(EUR, as reported — unscaled; 117 line items across 3 annual periods)
| Line item | 2022 | 2021 | 2020 |
|---|---|---|---|
| Income statement | |||
| Revenue | €751.1M | — | €591.3M |
| Operating expenses | €628.9M | — | €502.2M |
| Employee benefits expense | €53.3M | — | €45.5M |
| Raw materials & consumables used | €247.7M | — | €194.7M |
| Operating profit (EBIT) | €102.7M | — | €72.2M |
| Net finance income / (cost) | -€545.0K | — | -€1.2M |
| Finance costs | €826.0K | — | €1.4M |
| Profit before tax | €102.3M | — | €71.0M |
| Income tax expense | €27.5M | — | €19.7M |
| Profit for the year | €74.7M | €51.4M | €51.4M |
| — attributable to owners | €74.2M | — | €51.0M |
| — attributable to NCI | €585.0K | — | €344.0K |
| Total comprehensive income | €78.3M | €50.4M | — |
| Per share | |||
| Basic EPS | — | €1.48 | — |
| Diluted EPS | — | €1.47 | — |
| Free cash flow / share | — | €1.71 | — |
| Cash flow statement | |||
| Cash generated from operations | €165.0M | €121.0M | — |
| Net cash from operating activities | €145.1M | €97.8M | — |
| Net cash from investing activities | -€69.2M | -€49.6M | — |
| Purchase of PP&E (capex) | €36.7M | €38.1M | — |
| Purchase of intangibles | €13.3M | €11.1M | — |
| Net cash from financing activities | -€70.9M | -€1.3M | — |
| Dividends paid | €20.6M | €10.3M | — |
| Proceeds from borrowings | €9.3M | €46.8M | — |
| Repayments of borrowings | €29.8M | €35.0M | — |
| Lease liability payments | €45.0K | €3.7M | — |
| Balance sheet | |||
| Total assets | €743.8M | €595.0M | — |
| Non-current assets | €237.8M | €195.3M | — |
| Property, plant & equipment | €158.7M | €135.0M | — |
| Intangible assets & goodwill | €10.8M | €8.7M | — |
| Current assets | €506.0M | €399.7M | — |
| Inventories | €53.4M | €68.3M | — |
| Trade & other receivables | €21.8M | €18.3M | — |
| Cash & equivalents | €146.3M | €141.3M | €94.4M |
| Total equity | €290.1M | €229.1M | €185.4M |
| — attributable to owners | €288.5M | €229.0M | — |
| Non-controlling interests | €1.6M | €103.0K | — |
| Non-current liabilities | €60.3M | €71.6M | — |
| Current liabilities | €393.4M | €294.3M | — |
| Trade & other payables | €156.0M | €120.1M | — |
| Derived metrics | |||
| Free cash flow | €108.4M | €59.8M | — |
| Operating margin | 13.7% | — | 12.2% |
| Net margin | 10.0% | — | 8.7% |
| Return on equity | 25.8% | 22.4% | 27.7% |
| Cash conversion ratio | 1.94× | 1.91× | — |
| Capex coverage | 3.96× | 2.57× | — |
| Other reported items | |||
| Additions To Rightofuse Assets | €3.1M | €1.5M | — |
| Adjustments For Amortisation Expense | €7.4M | €6.4M | — |
| Adjustments For Decrease Increase In Contract Assets | -€51.4M | -€4.3M | — |
| Adjustments For Decrease Increase In Inventories | €14.8M | €13.9M | — |
| Adjustments For Decrease Increase In Other Operating Receivables | -€6.1M | -€23.9M | — |
| Adjustments For Decrease Increase In Trade Account Receivable | -€3.5M | -€1.1M | — |
| Adjustments For Depreciation Expense | €19.4M | €16.1M | — |
| Adjustments For Finance Income Cost | €545.0K | €1.2M | — |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | €167.0K | €0 | — |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €0 | €0 | — |
| Adjustments For Income Tax Expense | €27.5M | €19.7M | — |
| Adjustments For Increase Decrease In Other Operating Payables | €11.2M | €2.9M | — |
| Adjustments For Increase Decrease In Trade Account Payable | €35.9M | -€17.1M | — |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€267.0K | €58.0K | — |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€95.0K | €21.0K | — |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €0 | €0 | — |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €16.3M | €55.0K | — |
| Changes In Inventories of Finished Goods and Work In Progress | -€1.9M | — | -€920.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €585.0K | €344.0K | — |
| Comprehensive Income Attributable To Owners of Parent | €77.7M | €50.1M | — |
| Current Contract Assets | €168.6M | €117.2M | — |
| Current Contract Liabilities | €132.4M | €102.9M | — |
| Current Financial Liabilities | €52.2M | €33.5M | — |
| Current Tax Liabilities Current | €3.0M | €2.1M | — |
| Deferred Tax Assets | €5.5M | €6.0M | — |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €26.9M | — | €22.4M |
| Equity and Liabilities | €743.8M | €595.0M | — |
| Fee and Commission Expense | €59.9M | — | €96.7M |
| Finance Income | €281.0K | — | €193.0K |
| Gains Losses On Cash Flow Hedges Before Tax | €4.6M | -€1.5M | — |
| Gains Losses On Change In Fair Value of Derivatives | €49.0K | — | -€25.0K |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€82.0K | €152.0K | — |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €1.1M | -€352.0K | — |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €52.0K | €6.0K | — |
| Income Taxes Paid Refund Classified As Operating Activities | -€19.9M | -€23.1M | — |
| Increase Decrease In Cash and Cash Equivalents | €5.0M | €46.9M | — |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | -€875.0K | — |
| Increase Decrease Through Sharebased Payment Transactions | €3.9M | €628.0K | — |
| Increase Decrease Through Transfers and Other Changes Equity | €1.5M | €3.9M | — |
| Increase Decrease Through Treasury Share Transactions | -€2.1M | €0 | — |
| Intangible Assets Other Than Goodwill | €51.4M | €45.3M | — |
| Interest Paid Classified As Financing Activities | €826.0K | €1.4M | — |
| Interest Received Classified As Operating Activities | €281.0K | €193.0K | — |
| Investment Accounted For Using Equity Method | €7.2M | €412.0K | — |
| Issued Capital | €34.8M | €34.5M | — |
| Liabilities | €453.7M | €365.9M | — |
| Miscellaneous Other Operating Expense | €6.6M | — | €5.6M |
| Net Deferred Tax Liabilities | €9.9M | €1.6M | — |
| Noncurrent Financial Liabilities | €49.3M | €69.1M | — |
| Noncurrent Provisions For Employee Benefits | €1.1M | €1.1M | — |
| Other Comprehensive Income | €3.5M | -€945.0K | — |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €188.0K | €22.0K | — |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €3.4M | -€961.0K | — |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €136.0K | €16.0K | — |
| Other Current Financial Assets | €55.5M | €317.0K | — |
| Other Current Nonfinancial Liabilities | €31.9M | €22.6M | — |
| Other Current Receivables | €60.4M | €54.3M | — |
| Other Longterm Provisions | €9.9M | €1.4M | — |
| Other Revenue | €7.4M | — | €5.5M |
| Other Shortterm Provisions | €8.0M | €11.4M | — |
| Other Work Performed By Entity and Capitalised | €2.1M | — | €2.0M |
| Payments To Acquire Or Redeem Entitys Shares | €2.1M | €0 | — |
| Proceeds From Issuing Shares | €4.3M | €687.0K | — |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €0 | €0 | — |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €273.0K | €135.0K | — |
| Retained Earnings Profit Loss For Reporting Period | €74.2M | €51.0M | — |
| Revenue and Operating Income | €758.5M | — | €596.8M |
| Revenue From Sale of Goods | €811.0M | — | €688.0M |
| Services Expense | €63.4M | — | €50.2M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €46.0K | — | €4.0K |
| Share Premium | €81.2M | €77.2M | — |
Methodology
Every line item above is a fact tagged in SANLORENZOSPA/AMEGLIA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.